Drug Discovery and Development

Drug discovery is a process which is intended to identify a small synthetic molecule or a large biomolecule for comprehensive evaluation as a potential drug candidate. Broadly, the modern drug discovery process includes identification of disease to be treated and its unmet medical need, selection of a druggable molecular target and its validation, in vitro assay development followed by high throughput screening of compound libraries against the target to identify hits, and hit optimization to generate lead compounds that exhibit adequate potency and selectivity towards the biological target in vitro and which demonstrate efficacy in animal models of disease. Subsequently, the lead compounds are further optimized to improve their efficacy and pharmacokinetics before they advance towards drug development.

Drug development process can be segregated into preclinical and clinical development stages. In preclinical development, toxicological and safety pharmacology studies of the candidate are conducted in order to establish the maximum safe concentrations in animals and determine the adverse effect potential of the drug-in-development. Additionally, studies are conducted to finalize cost-effective processes required for manufacturing the candidate drug as well as deciding on its best formulation. If the candidate exhibits sufficient efficacy and safety in preclinical evaluation, permission is sought from drug regulatory agencies to initiate its clinical development wherein the safety and efficacy of the drug candidate is assessed in pilot and pivotal studies.

 

  • Computational approaches in drug discovery and precision medicine
  • Phosphonate chemistry in drug design and development
  • In silico methods for drug design and discovery
  • Neglected Diseases: Chagas Disease, Human African Trypanosomiasis, and Leishmaniasis
  • Anti-Tubercular drugs
  • Computational drug discovery for targeting of protein-protein interfaces
  • Multi-target-directed ligands (MTDL) in drug discovery: from design to pharmacological evaluation

Related Conference of Drug Discovery and Development

March 18-19, 2024

28th International Conference on Neurology & Neurophysiology

Zurich, Switzerland
April 11-12, 2024

36th World Congress on Neurorehabilitation

Amsterdam, Netherlands
April 11-12, 2024

38th European Neurology Congress

Amsterdam, Netherlands
April 11-12, 2024

36th World Neuroscience and Neurology Conferences

Amsterdam, Netherlands
May 30-31, 2024

2nd International conference on Neuro Surgery

Vienna, Austria
June 13-14, 2024

37th European Neurology Congress 2024

Rome, Italy
June 27-28, 2024

6th World Depression Congress

Paris, France
June 27-28, 2024

2nd International conference on Dementia

London, UK
July 11-12, 2024

4th Annual Dementia Congress

Vancouver, Canada
July 15-16, 2024

7th World Conference on Neuroscience

London, UK
July 18-19, 2024

36th World Conference on Neurology

Paris, France
August 13-14, 2024

14th Global Alzheimers Summit

Amsterdam, Netherlands
August 16-17, 2024

30th Annual Summit on Neuroscience & Neurological Disorders

Melbourne, Australia
October 31-01, 2024

7th Global Congress on Spine and Spinal Disorders

Amsterdam, Netherlands
December 05-06, 2024

7th World Congress on Epilepsy and Brain Disorders

Dubai, UAE

Drug Discovery and Development Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in